Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

Diabetic Medicine

Volumn 29, Issue 5, 2012, Pages 682-689

  Peyrot, M ^a,b   Barnett, A H ^c   Meneghini, L F ^d   Schumm Draeger, P M ^e  

^a UNIVERSITY OF MARYLAND   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

Adherence; Insulin therapy; Psychosocial; Questionnaire

Indexed keywords

INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CHINA; CROSS-SECTIONAL STUDY; EMOTIONAL DISORDER; FEMALE; FRANCE; GENERAL PRACTITIONER; GERMANY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTERNET; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; SPAIN; STRESS; TELEPHONE; TRAVEL; UNITED KINGDOM;

BLOOD GLUCOSE; CHINA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FRANCE; GERMANY; HEALTH BEHAVIOR; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; JAPAN; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SPAIN; TURKEY; UNITED STATES;

EID: 84859842346     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03605.x     Document Type: Article

References (21)

1. Dailey GE. Early insulin: an important therapeutic strategy. Diabetes Care 2005; 28: 220-221.
2. Davidson MB. Early insulin therapy for type2 diabetes. Diabetes Care 2005; 28: 222-224.
3. Home PD, Boulton AJM, Jimenez J, Landgraf R, Osterbrink B, Christiansen JS. Issues relating to the early or earlier use of insulin in type2 diabetes. Practical Diabetes Int 2003; 20: 63-71.
4. Del Prato S, Penno G, Miccoli R. Changing the treatment paradigm for type2 diabetes. Diabetes Care 2009; 32: S217-S222.
5. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R et al. Medical management of hyperglycemia in type2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32: 193-203.
6. Cramer J. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218-1224.
7. Rubin RR. Adherence to pharmacologic therapy in patients with type2 diabetes mellitus. Am J Med 2005; 118: 27S-34S.
8. Peyrot M, Rubin RR, Kruger D, Travis L. Correlates of insulin injection omission. Diabetes Care 2010; 33: 243-248.
9. Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: how well do adults follow prescriptions for insulin? Diabetes Care 2005; 28: 78-83.
10. Morris AD, Boyle DIR, McMahon D, MacDonald TM, Newton RW, for the DRTS/MEMO Collaboration. Adherence to insulin treatment, glycemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 1997; 350: 1505-1510.
11. Peyrot M, Rubin RR. Perceived medication benefits and their association with interest in using inhaled insulin in type2 diabetes: a model of patients' cognitive framework. Patient Prefer Adherence 2011; 5: 255-265.
12. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR et al. on behalf of the International DAWN Advisory Board. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs study (DAWN). Diabetes Care 2005; 28: 2673-2679.
13. Rubin RR, Peyrot M. Factors associated with physician perceptions of and willingness to recommend inhaled insulin. Curr Med Res Opin 2011; 27: 285-294.
14. Nakar S, Yitzhaki G, Rosenberg R, Vinker S. Transition to insulin in type2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers. J Diabetes Complications 2007; 21: 220-226.
15. Peyrot M. Psychological insulin resistance. Overcoming barriers to insulin therapy. Practical Diabetology 2004; 23: 6-12.
16. Grant RW, Wexler DJ, Watson AJ, Lester WT, Cagliero E, Campbell EG et al. How doctors choose medications to treat type2 diabetes: a national survey of specalists and academic generalists. Diabetes Care 2007; 30: 1448-1453.
17. Peyrot M, Skovlund S, Landgraf R. Epidemiology and correlates of weight worry in the multi-national Diabetes Attitudes, Wishes and Needs (DAWN) Study. Curr Med Res Opin 2009; 25: 1985-1993.
18. Brod M, Kongso JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009; 18: 23-32.
19. Wagner TH, Heisler M, Piette JD. Prescription drug co-payments and cost-related medication underuse. Health Econ Policy Law 2008; 3: 51-67.
20. Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE, on behalf of the International DAWN Advisory Panel. Psychosocial problems and barriers to improved diabetes management: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabet Med 2005; 22: 1379-1385.
21. Rubin RR, Peyrot M, Kruger DF, Travis LB. Barriers to insulin injection therapy: patient and health care provider perspectives. Diabetes Educ 2009; 35: 1014-1022.